Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
ACC/AHA classification
Stages A, B, C, D
o Treatment guidelines are in place for each stage/classification
HF compensatory mechanisms
o Sympathetic nervous system
o RAAS
o
o Ventricular hypertrophy
o Ventricular remodeling
HF complications
o Pulmonary complications
SOB
Pulmonary edema (especially with L-sided)
Arterial blood gases of
o Cardiogenic versus noncardiogenic pulmonary edema
Cardiogenic HF, cardiomyopathies, CAD, HTN
Noncardiogenic ARDS, high altitudes, lung injury
o Dysrhythmias
Medical management of HF
o Eliminate or reduce etiologic or contributory factors
o Reduce the workload of the heart by reducing afterload and preload
o Optimize all therapeutic regimens
o Prevent exacerbations of HF
o Medications are routinely prescribed for HF
ACE inhibitors (captopril, enalapril)
Dilate venules and arterioles
Improve renal blood flow
Relieve symptoms of HF
Play a pivotal role in the management of heart failure due
to systolic dysfunction
Angiotensin II receptor blockers (losartan, valsartan)
Promote reverse remodeling
Decrease morbidity and mortality
Beta-blockers (metoprolol) used in chronic HF only
Promote reverse remodeling
Decrease afterload
Inhibit SNS
Decrease morbidity and mortality
Diuretics (furosemide [loop], hydrochlorthiazide [thiazide],
spironolactone [K sparing]
Decrease fluid volume
Decrease preload
Decreased pulmonary venous pressure
Relieve symptoms of HF like edema
Digitalis
Increase contractility of the heart (+ inotropic efect)
Increase CO
Decrease HR (because the proper amount of blood is
being pumped out to the body and the heart wont try to
compensate by beating faster to get more blood out)
Goal of medical management
o Relief of symptoms
o Enhancement of cardiac performance